Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 442

Results For "CHI"

5487 News Found

IDMA set for its Diamond Jubilee celebrations on April 14-15th
News | April 13, 2022

IDMA set for its Diamond Jubilee celebrations on April 14-15th

The association has lined up a string of prominent speakers from the government and private sector. Seasoned veterans and industry bigwigs will grace the two-day event in Mumbai


Zydus to supply Sagent's caffeine citrate oral solution from Jarod
Biotech | April 13, 2022

Zydus to supply Sagent's caffeine citrate oral solution from Jarod

This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants


Switzerland grants conditional marketing authorisation for Novavax Covid-19 vaccine
Biotech | April 13, 2022

Switzerland grants conditional marketing authorisation for Novavax Covid-19 vaccine

Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland


One-dose HPV vaccine offers solid protection against cervical cancer
News | April 12, 2022

One-dose HPV vaccine offers solid protection against cervical cancer

This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls


Dr. Morepen launches advanced muscle food
Healthcare | April 12, 2022

Dr. Morepen launches advanced muscle food

Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities


Pharmapack Europe 2022 to open on May 18-19 in Paris
Packaging | April 12, 2022

Pharmapack Europe 2022 to open on May 18-19 in Paris

Pharmapack trends are a key barometer of global device and packing opportunities in 2022


ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine
Biotech | April 12, 2022

ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine

Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation


Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab
Biotech | April 11, 2022

Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab

Lilly may be eligible for up to US $ 225m in payments based upon the achievement of pre-specified development, regulatory and commercial milestones


New very-high-sensitivity rapid antigen test kits hit Australian market
News | April 11, 2022

New very-high-sensitivity rapid antigen test kits hit Australian market

New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia


Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule
Biotech | April 11, 2022

Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule

GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology